These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9915261)

  • 1. Relationship of dialysis membrane and cause-specific mortality.
    Bloembergen WE; Hakim RM; Stannard DC; Held PJ; Wolfe RA; Agodoa LY; Port FK
    Am J Kidney Dis; 1999 Jan; 33(1):1-10. PubMed ID: 9915261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of dose of hemodialysis and cause-specific mortality.
    Bloembergen WE; Stannard DC; Port FK; Wolfe RA; Pugh JA; Jones CA; Greer JW; Golper TA; Held PJ
    Kidney Int; 1996 Aug; 50(2):557-65. PubMed ID: 8840286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the dialysis membrane on mortality of chronic hemodialysis patients.
    Hakim RM; Held PJ; Stannard DC; Wolfe RA; Port FK; Daugirdas JT; Agodoa L
    Kidney Int; 1996 Aug; 50(2):566-70. PubMed ID: 8840287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study.
    Port FK; Wolfe RA; Hulbert-Shearon TE; Daugirdas JT; Agodoa LY; Jones C; Orzol SM; Held PJ
    Am J Kidney Dis; 2001 Feb; 37(2):276-86. PubMed ID: 11157367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.
    Vonesh EF; Snyder JJ; Foley RN; Collins AJ
    Kidney Int; 2004 Dec; 66(6):2389-401. PubMed ID: 15569331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients.
    Salahudeen AK; Dykes P; May W
    Nephrol Dial Transplant; 2003 Jul; 18(7):1339-44. PubMed ID: 12808171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival.
    Leypoldt JK; Cheung AK; Carroll CE; Stannard DC; Pereira BJ; Agodoa LY; Port FK
    Am J Kidney Dis; 1999 Feb; 33(2):349-55. PubMed ID: 10023649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.
    Krane V; Krieter DH; Olschewski M; März W; Mann JF; Ritz E; Wanner C
    Am J Kidney Dis; 2007 Feb; 49(2):267-75. PubMed ID: 17261429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of transplant outcomes in peritoneal and hemodialysis patients.
    Snyder JJ; Kasiske BL; Gilbertson DT; Collins AJ
    Kidney Int; 2002 Oct; 62(4):1423-30. PubMed ID: 12234315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of patient autonomy with increased transplantation and survival among new dialysis patients in the United States.
    Stack AG; Martin DR
    Am J Kidney Dis; 2005 Apr; 45(4):730-42. PubMed ID: 15806476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease.
    Jaar BG; Coresh J; Plantinga LC; Fink NE; Klag MJ; Levey AS; Levin NW; Sadler JH; Kliger A; Powe NR
    Ann Intern Med; 2005 Aug; 143(3):174-83. PubMed ID: 16061915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.
    Abe M; Hamano T; Wada A; Nakai S; Masakane I;
    PLoS One; 2017; 12(9):e0184424. PubMed ID: 28910324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States.
    Stack AG; Murthy BV; Molony DA
    Kidney Int; 2004 Jun; 65(6):2398-408. PubMed ID: 15149353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival by time of day of hemodialysis: analysis of United States Renal Data System Dialysis Morbidity and Mortality Waves III/IV.
    Abbott KC; Reynolds JC; Trespalacios FC; Cruess D; Agodoa LY;
    Am J Kidney Dis; 2003 Apr; 41(4):796-806. PubMed ID: 12666066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    Macleod AM; Campbell M; Cody JD; Daly C; Donaldson C; Grant A; Khan I; Rabindranath KS; Vale L; Wallace S
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003234. PubMed ID: 16034894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.